Literature DB >> 19533202

Significant association of metabolic syndrome with silent brain infarction in elderly people.

Hyung-Min Kwon1, Beom Joon Kim, Jin-Ho Park, Wi-Sun Ryu, Chi-Kyung Kim, Su-Ho Lee, Sang-Bae Ko, Hyunwoo Nam, Seung-Hoon Lee, Yong-Seok Lee, Byung-Woo Yoon.   

Abstract

A silent brain infarction (SBI) can predict clinical overt stroke or dementia. Studies focusing on the elderly population, where SBI is most common, are sparse. We examined the associations between SBI and metabolic syndrome (MetS) in healthy elderly individuals. Neurologically healthy subjects (1,254 persons, 723 males) aged > or =65 years who underwent brain MRI were evaluated. MetS was diagnosed following the AHA/NHLBI-2005 criteria. We examined associations between full syndrome (at least three of the five conditions) as well as its components and SBI while controlling for possible confounders. One hundred and ninety-seven subjects (15.7%) were found to have one or more SBIs on MRI. Age (1-year difference) was found to be significantly related to SBI prevalence (OR 1.09; 95% CI 1.05-1.12). MetS was significantly associated with SBI (OR 1.68; 95% CI 1.15-2.44). The component model of MetS showed a strong significance between elevated blood pressure (OR 1.89; 95% CI 1.23-2.91) and SBI. Subjects exhibiting more components of MetS showed more prevalent SBI and multiple SBIs. MetS was found to be significantly associated with SBI in neurologically healthy elderly people. The positive trend between the number of MetS components and SBI could be used as a diagnostic tool to predict and prevent future stroke.

Entities:  

Mesh:

Year:  2009        PMID: 19533202     DOI: 10.1007/s00415-009-5201-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

Review 1.  The deadly quartet revisited.

Authors:  P C Deedwania
Journal:  Am J Med       Date:  1998-07-06       Impact factor: 4.965

2.  Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia.

Authors:  T Uehara; M Tabuchi; E Mori
Journal:  Stroke       Date:  1999-02       Impact factor: 7.914

Review 3.  The dysmetabolic syndrome.

Authors:  L Groop; M Orho-Melander
Journal:  J Intern Med       Date:  2001-08       Impact factor: 8.989

4.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

5.  Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study.

Authors:  Sarah E Vermeer; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Monique M B Breteler
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

6.  Significant associations of metabolic syndrome and its components with silent lacunar infarction in middle aged subjects.

Authors:  K Park; N Yasuda; S Toyonaga; E Tsubosaki; H Nakabayashi; K Shimizu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-02-12       Impact factor: 10.154

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Silent lacunar infarction on magnetic resonance imaging (MRI): risk factors.

Authors:  S Shintani; T Shiigai; T Arinami
Journal:  J Neurol Sci       Date:  1998-09-18       Impact factor: 3.181

9.  Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study.

Authors:  W T Longstreth; C Bernick; T A Manolio; N Bryan; C A Jungreis; T R Price
Journal:  Arch Neurol       Date:  1998-09

10.  The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

Authors:  E Bonora; G Targher; G Formentini; F Calcaterra; S Lombardi; F Marini; L Zenari; F Saggiani; M Poli; S Perbellini; A Raffaelli; L Gemma; L Santi; R C Bonadonna; M Muggeo
Journal:  Diabet Med       Date:  2004-01       Impact factor: 4.359

View more
  17 in total

1.  Metabolic syndrome and localization of white matter hyperintensities in the elderly population.

Authors:  Florence Portet; Adam M Brickman; Yaakov Stern; Nikolaos Scarmeas; Jordan Muraskin; Frank A Provenzano; Claudine Berr; Alain Bonafé; Sylvaine Artero; Karen Ritchie; Tasnime N Akbaraly
Journal:  Alzheimers Dement       Date:  2012-06-06       Impact factor: 21.566

Review 2.  Advances in cerebrovascular disease research in the last year.

Authors:  Mirta López; Antoni Dávalos
Journal:  J Neurol       Date:  2010-11-27       Impact factor: 4.849

Review 3.  Impact of metabolic syndrome on cognition and brain: a selected review of the literature.

Authors:  Kathy F Yates; Victoria Sweat; Po Lai Yau; Michael M Turchiano; Antonio Convit
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

4.  Neural correlates of taste and pleasantness evaluation in the metabolic syndrome.

Authors:  Erin Green; Aaron Jacobson; Lori Haase; Claire Murphy
Journal:  Brain Res       Date:  2015-04-02       Impact factor: 3.252

Review 5.  White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.

Authors:  Freddy J Alfaro; Anna Gavrieli; Patricia Saade-Lemus; Vasileios-Arsenios Lioutas; Jagriti Upadhyay; Vera Novak
Journal:  Metabolism       Date:  2017-09-08       Impact factor: 8.694

6.  Association of obesity with cerebral microbleeds in neurologically asymptomatic elderly subjects.

Authors:  Chi Kyung Kim; Hyung-Min Kwon; Seung-Hoon Lee; Beom Joon Kim; Wi-Sun Ryu; Hyuk Tae Kwon; Byung-Woo Yoon
Journal:  J Neurol       Date:  2012-05-23       Impact factor: 4.849

7.  Retinal vessel alterations and cerebral white matter microstructural damage in obese adolescents with metabolic syndrome.

Authors:  Po Lai Yau; Minsung Kim; Aziz Tirsi; Antonio Convit
Journal:  JAMA Pediatr       Date:  2014-12-01       Impact factor: 16.193

8.  Where will the next generation of stroke treatments come from?

Authors:  D W Howells; G A Donnan
Journal:  PLoS Med       Date:  2010-03-02       Impact factor: 11.069

Review 9.  Risk of "silent stroke" in patients older than 60 years: risk assessment and clinical perspectives.

Authors:  Jae-Sung Lim; Hyung-Min Kwon
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

10.  The relationship between metabolic syndrome and target organ damage in Ghanaian with stage-2 hypertension.

Authors:  B M Bello-Rodriguez; G Sanchez-Cruz; F Delgado-Bustillo; G Asiama
Journal:  Ghana Med J       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.